Ruxience

Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US
Pharmaforum
Fri, 01/24/20 - 10:11 am
Pfizer
Roche
biosimilars
Avastin
Zirabev
Herceptin
Trazimera
Rituxan
Ruxience
FDA approves Rituxan biosimilar
Beckers Hospital Review
Tue, 07/23/19 - 07:40 pm
Pfizer
biosimilars
FDA
Ruxience
cancer
autoimmune disease
Genentech